๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2/interferon

โœ Scribed by Ken-ryu Han; Allan J. Pantuck; Arie S. Belldegrun


Book ID
107554635
Publisher
Springer
Year
2002
Tongue
English
Weight
112 KB
Volume
3
Category
Article
ISSN
1527-2737

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase I study of subcutaneous recombin
โœ Mark J. Ratain; Edwin R. Priest; Linda Janisch; Nicholas J. Vogelzang ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 495 KB ๐Ÿ‘ 2 views

Background. Both recombinant in1 erferon alfa and interleukin-2 (IL-2) have been shown to lave some activity as single agents in metastatic renal cj !I1 cancer (RCC), although their activity is minimal in mo -e common solid tumors. Recent preclinical studies hav ? suggested that the combination of t